vs
PRECISION BIOSCIENCES INC（DTIL）与REGIS CORP（RGS）财务数据对比。点击上方公司名可切换其他公司
REGIS CORP的季度营收约是PRECISION BIOSCIENCES INC的1.7倍（$57.1M vs $34.2M），PRECISION BIOSCIENCES INC净利率更高（58.9% vs 0.8%，领先58.1%），PRECISION BIOSCIENCES INC同比增速更快（5261.1% vs 22.3%），REGIS CORP自由现金流更多（$891.0K vs $-11.3M），过去两年PRECISION BIOSCIENCES INC的营收复合增速更高（39.5% vs 7.8%）
精准生物科学公司是一家上市的美国临床阶段基因编辑企业，总部位于北卡罗来纳州达勒姆，成立于2006年。该公司依托自主研发的ARCUS基因组编辑平台，专注于开发体内和体外两类基因编辑疗法。
瑞吉斯公司是一家美国美发沙龙运营商，总部位于明尼苏达州明尼阿波利斯市。截至2021年8月，该集团旗下拥有5563家加盟沙龙以及276家直营门店，是北美地区规模领先的美发沙龙连锁经营企业。
DTIL vs RGS — 直观对比
营收规模更大
RGS
是对方的1.7倍
$34.2M
营收增速更快
DTIL
高出5238.9%
22.3%
净利率更高
DTIL
高出58.1%
0.8%
自由现金流更多
RGS
多$12.2M
$-11.3M
两年增速更快
DTIL
近两年复合增速
7.8%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $34.2M | $57.1M |
| 净利润 | $20.1M | $456.0K |
| 毛利率 | — | — |
| 营业利润率 | 36.6% | 10.8% |
| 净利率 | 58.9% | 0.8% |
| 营收同比 | 5261.1% | 22.3% |
| 净利润同比 | 213.5% | -94.0% |
| 每股收益（稀释后） | $2.62 | $0.16 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DTILRGS
| Q4 25 | $34.2M | $57.1M | ||
| Q3 25 | $13.0K | $59.0M | ||
| Q2 25 | $18.0K | $60.4M | ||
| Q1 25 | $29.0K | $57.0M | ||
| Q4 24 | $638.0K | $46.7M | ||
| Q3 24 | $576.0K | $46.1M | ||
| Q2 24 | $49.9M | $49.4M | ||
| Q1 24 | $17.6M | $49.2M |
净利润DTILRGS
| Q4 25 | $20.1M | $456.0K | ||
| Q3 25 | $-21.8M | $1.4M | ||
| Q2 25 | $-23.5M | $116.5M | ||
| Q1 25 | $-20.6M | $250.0K | ||
| Q4 24 | — | $7.6M | ||
| Q3 24 | $-16.4M | $-853.0K | ||
| Q2 24 | $32.7M | $91.2M | ||
| Q1 24 | $8.6M | $-2.3M |
营业利润率DTILRGS
| Q4 25 | 36.6% | 10.8% | ||
| Q3 25 | -158976.9% | 10.0% | ||
| Q2 25 | -121538.9% | 12.1% | ||
| Q1 25 | -76248.3% | 8.8% | ||
| Q4 24 | — | 11.8% | ||
| Q3 24 | -3693.6% | 4.6% | ||
| Q2 24 | 48.4% | — | ||
| Q1 24 | -23.8% | 8.3% |
净利率DTILRGS
| Q4 25 | 58.9% | 0.8% | ||
| Q3 25 | -167476.9% | 2.3% | ||
| Q2 25 | -130666.7% | 192.9% | ||
| Q1 25 | -70913.8% | 0.4% | ||
| Q4 24 | — | 16.4% | ||
| Q3 24 | -2851.6% | -1.9% | ||
| Q2 24 | 65.6% | 184.7% | ||
| Q1 24 | 48.8% | -4.7% |
每股收益（稀释后）DTILRGS
| Q4 25 | $2.62 | $0.16 | ||
| Q3 25 | $-1.84 | $0.49 | ||
| Q2 25 | $-2.13 | $43.67 | ||
| Q1 25 | $-2.21 | $0.08 | ||
| Q4 24 | — | $2.71 | ||
| Q3 24 | $-2.25 | $-0.36 | ||
| Q2 24 | $4.67 | $38.40 | ||
| Q1 24 | $1.70 | $-1.00 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $115.6M | $18.4M |
| 总债务越低越好 | — | $113.3M |
| 股东权益账面价值 | $92.2M | $188.7M |
| 总资产 | $154.4M | $588.3M |
| 负债/权益比越低杠杆越低 | — | 0.60× |
8季度趋势，按日历期对齐
现金及短期投资DTILRGS
| Q4 25 | $115.6M | $18.4M | ||
| Q3 25 | $44.9M | $16.6M | ||
| Q2 25 | $62.2M | $17.0M | ||
| Q1 25 | $77.2M | $13.3M | ||
| Q4 24 | $86.3M | $10.2M | ||
| Q3 24 | $101.2M | $6.3M | ||
| Q2 24 | $123.6M | $10.1M | ||
| Q1 24 | $137.8M | $5.9M |
总债务DTILRGS
| Q4 25 | — | $113.3M | ||
| Q3 25 | — | $111.3M | ||
| Q2 25 | — | $110.8M | ||
| Q1 25 | — | $112.0M | ||
| Q4 24 | — | $111.5M | ||
| Q3 24 | — | $95.2M | ||
| Q2 24 | — | $99.5M | ||
| Q1 24 | — | $179.7M |
股东权益DTILRGS
| Q4 25 | $92.2M | $188.7M | ||
| Q3 25 | $16.6M | $187.6M | ||
| Q2 25 | $34.1M | $185.6M | ||
| Q1 25 | $49.3M | $68.6M | ||
| Q4 24 | $56.4M | $66.7M | ||
| Q3 24 | $64.9M | $56.4M | ||
| Q2 24 | $74.7M | $56.8M | ||
| Q1 24 | $37.2M | $-35.8M |
总资产DTILRGS
| Q4 25 | $154.4M | $588.3M | ||
| Q3 25 | $93.5M | $592.1M | ||
| Q2 25 | $108.9M | $599.0M | ||
| Q1 25 | $124.4M | $511.2M | ||
| Q4 24 | $136.4M | $530.1M | ||
| Q3 24 | $153.3M | $508.9M | ||
| Q2 24 | $165.8M | $530.5M | ||
| Q1 24 | $184.7M | $543.7M |
负债/权益比DTILRGS
| Q4 25 | — | 0.60× | ||
| Q3 25 | — | 0.59× | ||
| Q2 25 | — | 0.60× | ||
| Q1 25 | — | 1.63× | ||
| Q4 24 | — | 1.67× | ||
| Q3 24 | — | 1.69× | ||
| Q2 24 | — | 1.75× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-11.3M | $1.7M |
| 自由现金流经营现金流 - 资本支出 | $-11.3M | $891.0K |
| 自由现金流率自由现金流/营收 | -32.9% | 1.6% |
| 资本支出强度资本支出/营收 | 0.1% | 1.4% |
| 现金转化率经营现金流/净利润 | -0.56× | 3.65× |
| 过去12个月自由现金流最近4个季度 | — | $14.9M |
8季度趋势，按日历期对齐
经营现金流DTILRGS
| Q4 25 | $-11.3M | $1.7M | ||
| Q3 25 | $-15.3M | $2.3M | ||
| Q2 25 | $-20.3M | $6.8M | ||
| Q1 25 | $-19.1M | $6.2M | ||
| Q4 24 | $-58.4M | $2.1M | ||
| Q3 24 | $-5.9M | $-1.3M | ||
| Q2 24 | $-14.9M | $5.1M | ||
| Q1 24 | $-19.0M | $-277.0K |
自由现金流DTILRGS
| Q4 25 | $-11.3M | $891.0K | ||
| Q3 25 | — | $1.9M | ||
| Q2 25 | $-20.3M | $6.2M | ||
| Q1 25 | $-19.1M | $5.9M | ||
| Q4 24 | $-58.7M | $1.7M | ||
| Q3 24 | $-6.0M | $-1.4M | ||
| Q2 24 | $-14.9M | $5.1M | ||
| Q1 24 | $-19.1M | $-326.0K |
自由现金流率DTILRGS
| Q4 25 | -32.9% | 1.6% | ||
| Q3 25 | — | 3.2% | ||
| Q2 25 | -112627.8% | 10.3% | ||
| Q1 25 | -65917.2% | 10.3% | ||
| Q4 24 | -9199.8% | 3.6% | ||
| Q3 24 | -1033.2% | -3.0% | ||
| Q2 24 | -29.9% | 10.3% | ||
| Q1 24 | -108.4% | -0.7% |
资本支出强度DTILRGS
| Q4 25 | 0.1% | 1.4% | ||
| Q3 25 | 0.0% | 0.7% | ||
| Q2 25 | 11.1% | 0.9% | ||
| Q1 25 | 220.7% | 0.6% | ||
| Q4 24 | 39.2% | 0.9% | ||
| Q3 24 | 6.8% | 0.0% | ||
| Q2 24 | 0.1% | 0.0% | ||
| Q1 24 | 0.5% | 0.1% |
现金转化率DTILRGS
| Q4 25 | -0.56× | 3.65× | ||
| Q3 25 | — | 1.68× | ||
| Q2 25 | — | 0.06× | ||
| Q1 25 | — | 24.80× | ||
| Q4 24 | — | 0.28× | ||
| Q3 24 | — | — | ||
| Q2 24 | -0.45× | 0.06× | ||
| Q1 24 | -2.21× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DTIL
暂无分部数据
RGS
| Franchise Segment | $37.9M | 66% |
| Royalty | $13.6M | 24% |
| Other | $2.8M | 5% |
| Fees | $1.8M | 3% |
| Franchise Fees | $1.0M | 2% |
